Sangamo Therapeutics
0 followers
SGMO
Performance
About Sangamo Therapeutics
Sangamo Therapeutics develops gene-based therapeutics across multiple platform modalities, including gene therapy, gene editing, cell therapy, and gene regulation. The company focuses on genomic medicines to treat severe diseases with limited current options, leveraging zinc finger technologies and delivery solutions to reach neurological, hematologic, and other systemic conditions. Its pipeline includes programs in Fabry disease and hemophilia A, as well as neurodegenerative and prion-related targets, positioned in the United States. Sangamo emphasizes translating scientific discoveries into curative therapies through a multi-platform approach and ongoing clinical development.